Docebo Inc.
DCBO
$17.19
-$0.45-2.55%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 65.62M | 63.04M | 61.62M | 60.73M | 57.30M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 65.62M | 63.04M | 61.62M | 60.73M | 57.30M |
| Cost of Revenue | 14.35M | 12.88M | 12.26M | 11.73M | 11.40M |
| Gross Profit | 51.27M | 50.16M | 49.36M | 49.00M | 45.90M |
| SG&A Expenses | 33.93M | 27.53M | 28.23M | 29.96M | 29.87M |
| Depreciation & Amortization | 1.92M | 798.00K | 743.00K | 847.00K | 798.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 65.66M | 53.35M | 53.38M | 54.65M | 55.47M |
| Operating Income | -39.00K | 9.69M | 8.24M | 6.08M | 1.83M |
| Income Before Tax | -1.90M | 9.16M | 8.25M | 4.68M | 2.36M |
| Income Tax Expenses | -284.00K | -17.69M | 2.14M | 1.61M | 883.00K |
| Earnings from Continuing Operations | -1.62M | 26.85M | 6.11M | 3.08M | 1.47M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.62M | 26.85M | 6.11M | 3.08M | 1.47M |
| EBIT | -39.00K | 9.69M | 8.24M | 6.08M | 1.83M |
| EBITDA | 1.13M | 9.99M | 8.56M | 6.44M | 2.63M |
| EPS Basic | -0.06 | 0.93 | 0.21 | 0.10 | 0.05 |
| Normalized Basic EPS | -0.04 | 0.21 | 0.18 | 0.12 | 0.05 |
| EPS Diluted | -0.06 | 0.92 | 0.21 | 0.10 | 0.05 |
| Normalized Diluted EPS | -0.04 | 0.20 | 0.18 | 0.12 | 0.05 |
| Average Basic Shares Outstanding | 28.08M | 28.73M | 28.75M | 29.56M | 30.26M |
| Average Diluted Shares Outstanding | 28.73M | 29.42M | 29.46M | 30.23M | 30.93M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |